Rani Therapeutics Holdings Inc (NASDAQ:RANI) has a beta value of 0.13 and has seen 21.46 million shares traded in the recent trading session. The company, currently valued at $75.86M, closed the recent trade at $2.59 per share which meant it gained $0.57 on the day or 28.22% during that session. The RANI stock price is -237.84% off its 52-week high price of $8.75 and 29.73% above the 52-week low of $1.82. If we look at the company’s 10-day average daily trading volume, we find that it stood at 61600.0 shares traded. The 3-month trading volume is 59.03K shares.
The consensus among analysts is that Rani Therapeutics Holdings Inc (RANI) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Rani Therapeutics Holdings Inc (NASDAQ:RANI) trade information
Sporting 28.22% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the RANI stock price touched $2.59 or saw a rise of 9.76%. Year-to-date, Rani Therapeutics Holdings Inc shares have moved -21.99%, while the 5-day performance has seen it change 14.60%. Over the past 30 days, the shares of Rani Therapeutics Holdings Inc (NASDAQ:RANI) have changed 9.28%. Short interest in the company has seen 0.79 million shares shorted with days to cover at 10.51.
Wall Street analysts have a consensus price target for the stock at $10, which means that the shares’ value could jump 74.1% from the levels at last check today.. The projected low price target is $9.0 while the price target rests at a high of $28.0. In that case, then, we find that the latest price level in today’s session is -981.08% off the targeted high while a plunge would see the stock gain -247.49% from the levels at last check today..
Rani Therapeutics Holdings Inc (RANI) estimates and forecasts
Figures show that Rani Therapeutics Holdings Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -55.03% over the past 6 months, with this year growth rate of 26.32%, compared to 17.40% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 0.28% over the past 5 years. Earnings growth for 2024 is a modest 7.44% while over the next 5 years, the company’s earnings are expected to decrease by -9.40%.
RANI Dividends
Rani Therapeutics Holdings Inc is expected to release its next earnings report on 2024-Nov-08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Rani Therapeutics Holdings Inc (NASDAQ:RANI)’s Major holders
Insiders own 43.90% of the company shares, while shares held by institutions stand at 10.06% with a share float percentage of 17.93%. Investors are also buoyed by the number of investors in a company, with Rani Therapeutics Holdings Inc having a total of 36.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.71 million shares worth more than $2.7 million. As of 2024-06-30, VANGUARD GROUP INC held 2.7265% of shares outstanding.
The other major institutional holder is NAN FUNG GROUP HOLDINGS LTD, with the holding of over 0.49 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.88 million and represent 1.8959% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Jun 30, 2024 , the former fund manager holds about 1.77% shares in the company for having 518.7 shares of worth $1.37 million while later fund manager owns 172.98 shares of worth $0.46 million as of Jun 30, 2024 , which makes it owner of about 0.59% of company’s outstanding stock.
